Crescent Capital BDC, Inc. CCAP
Finance: Consumer Services · data as of November 13, 2026
Crescent Capital BDC, Inc. (CCAP) is a financial company listed in the US with a market value of about $373M. In the twelve months to September 30, 2026 it had revenue of $10M and net income of -$156000, a net margin of -1.5%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is financial health (2/5); the weakest is future growth (0/5).
Key numbers: a price to free cash flow of 11.3, a 5-year average ROIC of -5%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 95% below the current price.
About Crescent Capital BDC
Crescent Capital BDC is listed in the US and classified in finance: consumer services. It was profitable in 6 of the last 6 years in our data. Its share count rose by 20% over three years (dilution for shareholders).
Score: 1.2 / 5
Checks passed
- P/FCF below 20
- Profitable 5 years in a row
- Positive free cash flow
- Liabilities below 60% of assets
- Pays a dividend
- Dividend 3 years in a row
Checks not passed
- P/E below 25
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $10M | — | — | — | — | — | — |
| Net income | -$156000 | $35M | $74M | $84M | $16M | $84M | $55M |
| Free cash flow | $33M | — | — | — | — | — | — |
| EPS (diluted) | $-0.00 | $0.91 | $2.40 | $2.30 | $1.93 | $1.67 | $1.80 |
| Net margin | -1.5% | — | — | — | — | — | — |
| ROIC | — | -6.2% | -6.6% | -6.3% | -3.5% | -3.3% | -3.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 7 analysts is $11.39, 12% above the current price; targets range from $10.00 to $14.00; the consensus rating is “Hold”; expected EPS is $1.50 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Crescent Capital BDC stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 95% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Crescent Capital BDC pay a dividend?
Yes. The dividend yield is about 16.45%, and it has paid dividends for 6 years in our data.
Is Crescent Capital BDC a good stock to buy?
We do not give buy or sell advice. Crescent Capital BDC scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.